AC
RMD icon

AXQ Capital’s ResMed RMD Stock Holding History

AXQ Capital’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$306K Buy
+1,569
New +$325K 0.03% 609
2023
Q3 		– Sell
-2,374
Closed -$519K – 574
2023
Q2 		$519K Buy
+2,374
New +$529K 0.64% 31

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

AXQ Capital's RMD Position: Q2 2026 in Review

AXQ Capital opened a new position in ResMed (RMD) in Q2 2026: 1,569 shares worth $306K. The stake represents 0.03% of the portfolio and ranks #609 among its holdings. This is a return to the name: AXQ Capital previously reported a position in RMD as recently as Q2 2023.

AXQ Capital first reported a position in RMD in Q2 2023 and has held it in 2 quarters since. The position peaked at $519K in Q2 2023. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • AXQ Capital held 1,569 shares of ResMed worth $306K as of Q2 2026.
  • ResMed was a new AXQ Capital position in Q2 2026.
  • ResMed made up 0.03% of AXQ Capital's portfolio in Q2 2026, its #609 holding.
  • AXQ Capital first reported a position in ResMed in Q2 2023 and has held it in 2 quarters since.
  • AXQ Capital's ResMed position peaked at $519K in Q2 2023.
  • 887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on AXQ Capital's 13F filing for Q2 2026, filed 6 Aug 2026.